Cargando…

Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India

BACKGROUND AND AIMS: The impact of coronavirus disease-2019 (COVID-19) on liver function remains to be fully elucidated. This study was designed to investigate such and determine the clinical significance in determining mortality risk. METHODS: A retrospective study was conducted in patients with CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalal, Chetan R., Joshi, Harshad, Kumar, Vivek, Gopal, Divya, Rathod, Darshana, Shukla, Ashish, Gianchandani, Tarang, Bhatt, Chetan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666361/
https://www.ncbi.nlm.nih.gov/pubmed/34966651
http://dx.doi.org/10.14218/JCTH.2020.00099
_version_ 1784614191991095296
author Kalal, Chetan R.
Joshi, Harshad
Kumar, Vivek
Gopal, Divya
Rathod, Darshana
Shukla, Ashish
Gianchandani, Tarang
Bhatt, Chetan
author_facet Kalal, Chetan R.
Joshi, Harshad
Kumar, Vivek
Gopal, Divya
Rathod, Darshana
Shukla, Ashish
Gianchandani, Tarang
Bhatt, Chetan
author_sort Kalal, Chetan R.
collection PubMed
description BACKGROUND AND AIMS: The impact of coronavirus disease-2019 (COVID-19) on liver function remains to be fully elucidated. This study was designed to investigate such and determine the clinical significance in determining mortality risk. METHODS: A retrospective study was conducted in patients with COVID-19 from March 2020 to July 2020. Clinical details were retrieved from electronic medical records to obtain clinical characteristics, medical history, laboratory tests, therapeutic intervention, and outcome data. RESULTS: A total of 184 patients with COVID-19 were included (median age: 45.5 years), comprised of 62.5% men. In total, 22 (12.0%) patients had severe infection and 162 (88.0%) had mild to moderate infection. Overall, 95 (51.6%) showed abnormal liver function test (LFT) and 17 (9.2%) showed normal LFT at admission. The median age, hospital stay, and LFT were significantly higher in severe vs. non-severe infection (p<0.001). Out of 12 deaths, the majority were due to severe infection (n=11). Deaths were also due to acute respiratory distress syndrome (n=5), cardiac reasons (n=3), and sepsis with multiorgan failure (n=3). The median age, hospital stay and number of intensive care unit admissions were higher in patients having abnormal LFT compared to normal LFT. Incidence of elevated aspartate aminotransferase (42.8% and 40.4%), alanine transaminase (43.7% and 41.6%), and hypoalbuminemia (71.4% and72.7%) at admission and discharge were more common in severe infection. The mean survival was significantly lower in severe infection compared to those with non-severe disease (17.2 vs. 52.3 days; p<0.001). CONCLUSIONS: Incidence of abnormal liver function was higher in patients with severe COVID-19 and was associated with prolonged hospital stay; mortality was associated with severity of COVID-19. For ruling out the risk of liver injury, it is crucial to vigilantly monitor the liver function parameters in patients with COVID-19 admitted to hospital.
format Online
Article
Text
id pubmed-8666361
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher XIA & HE Publishing Inc.
record_format MEDLINE/PubMed
spelling pubmed-86663612021-12-28 Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India Kalal, Chetan R. Joshi, Harshad Kumar, Vivek Gopal, Divya Rathod, Darshana Shukla, Ashish Gianchandani, Tarang Bhatt, Chetan J Clin Transl Hepatol Original Article BACKGROUND AND AIMS: The impact of coronavirus disease-2019 (COVID-19) on liver function remains to be fully elucidated. This study was designed to investigate such and determine the clinical significance in determining mortality risk. METHODS: A retrospective study was conducted in patients with COVID-19 from March 2020 to July 2020. Clinical details were retrieved from electronic medical records to obtain clinical characteristics, medical history, laboratory tests, therapeutic intervention, and outcome data. RESULTS: A total of 184 patients with COVID-19 were included (median age: 45.5 years), comprised of 62.5% men. In total, 22 (12.0%) patients had severe infection and 162 (88.0%) had mild to moderate infection. Overall, 95 (51.6%) showed abnormal liver function test (LFT) and 17 (9.2%) showed normal LFT at admission. The median age, hospital stay, and LFT were significantly higher in severe vs. non-severe infection (p<0.001). Out of 12 deaths, the majority were due to severe infection (n=11). Deaths were also due to acute respiratory distress syndrome (n=5), cardiac reasons (n=3), and sepsis with multiorgan failure (n=3). The median age, hospital stay and number of intensive care unit admissions were higher in patients having abnormal LFT compared to normal LFT. Incidence of elevated aspartate aminotransferase (42.8% and 40.4%), alanine transaminase (43.7% and 41.6%), and hypoalbuminemia (71.4% and72.7%) at admission and discharge were more common in severe infection. The mean survival was significantly lower in severe infection compared to those with non-severe disease (17.2 vs. 52.3 days; p<0.001). CONCLUSIONS: Incidence of abnormal liver function was higher in patients with severe COVID-19 and was associated with prolonged hospital stay; mortality was associated with severity of COVID-19. For ruling out the risk of liver injury, it is crucial to vigilantly monitor the liver function parameters in patients with COVID-19 admitted to hospital. XIA & HE Publishing Inc. 2021-12-28 2021-05-13 /pmc/articles/PMC8666361/ /pubmed/34966651 http://dx.doi.org/10.14218/JCTH.2020.00099 Text en © 2021 Authors. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kalal, Chetan R.
Joshi, Harshad
Kumar, Vivek
Gopal, Divya
Rathod, Darshana
Shukla, Ashish
Gianchandani, Tarang
Bhatt, Chetan
Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India
title Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India
title_full Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India
title_fullStr Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India
title_full_unstemmed Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India
title_short Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India
title_sort clinical significance of liver function abnormality in patients with covid-19: a single-center experience from western india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666361/
https://www.ncbi.nlm.nih.gov/pubmed/34966651
http://dx.doi.org/10.14218/JCTH.2020.00099
work_keys_str_mv AT kalalchetanr clinicalsignificanceofliverfunctionabnormalityinpatientswithcovid19asinglecenterexperiencefromwesternindia
AT joshiharshad clinicalsignificanceofliverfunctionabnormalityinpatientswithcovid19asinglecenterexperiencefromwesternindia
AT kumarvivek clinicalsignificanceofliverfunctionabnormalityinpatientswithcovid19asinglecenterexperiencefromwesternindia
AT gopaldivya clinicalsignificanceofliverfunctionabnormalityinpatientswithcovid19asinglecenterexperiencefromwesternindia
AT rathoddarshana clinicalsignificanceofliverfunctionabnormalityinpatientswithcovid19asinglecenterexperiencefromwesternindia
AT shuklaashish clinicalsignificanceofliverfunctionabnormalityinpatientswithcovid19asinglecenterexperiencefromwesternindia
AT gianchandanitarang clinicalsignificanceofliverfunctionabnormalityinpatientswithcovid19asinglecenterexperiencefromwesternindia
AT bhattchetan clinicalsignificanceofliverfunctionabnormalityinpatientswithcovid19asinglecenterexperiencefromwesternindia